Kunming Medical University
19
2
3
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
5.3%
1 terminated/withdrawn out of 19 trials
88.9%
+2.4% vs industry average
11%
2 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (19)
Artificial Intelligence-assisted Diagnosis
Role: collaborator
Effects of Otago-based Multicomponent Exercise on Sarcopenia in Pre-Frailty Older Adults in Nursing Homes: A Randomized Controlled Trial
Role: collaborator
Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer
Role: collaborator
The Systematic Evaluation of the Surgery, Using the Ratio of the Window Area to the Volume of Bone Graft Material
Role: lead
A Study to Investigate the Safety, Immunogenicity of Bivalent mRNA Vaccine RQ3027 and RQ3025 as a Booster Dose in Healthy Adults
Role: collaborator
A Clinical Study of the Combination of Anlotinib and Aumolertinib in the First-line Treatment of Advanced NSCLC With EGFR 21L858R Mutation
Role: lead
The ENIGMA Study: Eastern Inflammatory Bowel Disease Gut Microbiota
Role: collaborator
Diagnostic and Prognostic Model of Pulmonary Fibrosis After COVID-19 Pneumonia and Mechanism Study
Role: lead
Differentiation HHD From HCM (EARLY-MYO-HHD)
Role: collaborator
5-HTR2A, DRD2,and COMT Genes Polymorphisms and Olanzapine Plasma Concentration in Treatment of Early-onset Schizophrenia
Role: lead
The Imaging Genetic Study of Type 2 Diabetes and Depression
Role: lead
The Imaging Genetic Study of Schizophrenia and Family
Role: lead
The Imaging Genetic Study of the Core Family of Obsessive-compulsive Disorder (OCD) Patient
Role: lead
A Neuroimaging and Epigenetic Investigation of Antidepressants in Depression
Role: lead
Effects of Open Thoracic Paravertebral Block on Postoperative Analgesia
Role: lead
Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 2
Role: collaborator
Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 1
Role: collaborator
CIK Cell Transfusion Plus Gefitinib As Second Or Third-Line Treatment for Advanced Adenocarcinoma Non-Small Cell Lung Cancer
Role: lead
Extracorporeal Cardiac Shock Wave Therapy (CSWT) for Treatment of Coronary Artery Disease
Role: lead
All 19 trials loaded